SynthesisFrontiers in pharmacology2022

The Outcomes of Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2I) on Diabetes-Associated Neuropathy: A Systematic Review and meta-Analysis.

Mahmoud KandeelPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.